Robinson College, Cambridge, UK
The study of helicases and translocases is a rapidly growing field, fuelled by the fact that helicase defects are associated with inherited human diseases including neurological disorders, cancer, and aging processes. Pathogens encode helicases, making these enzymes targets for new anti-viral or anti-bacterial therapies. New discoveries linking helicases to disease states are being discovered regularly, due to the fact that helicases and translocases participate in a wide variety of cellular functions.
Early application deadline: 7 May 2013.
Application is now closed. If you would like to attend this meeting please contact the Conference Office.
Abstract submission deadline: 7 May 2013.
Abstract submission is now closed. If you would like to submit an abstract for this meeting please contact the Conference Office.